Repository logo
 
Publication

Intrauterine Blood Transfusion for Fetal Anemia Treatment – The Experience of 14 Years of a Prenatal Diagnosis Center in Portugal

dc.contributor.authorRijo, C
dc.contributor.authorCohen, A
dc.contributor.authorMartins, AT
dc.contributor.authorCruz, J
dc.contributor.authorQueirós, A
dc.contributor.authorRamos, H
dc.contributor.authorCorreia, J
dc.date.accessioned2022-07-28T09:24:14Z
dc.date.available2022-07-28T09:24:14Z
dc.date.issued2016
dc.description.abstractOverview and aims: Intrauterine blood transfusion (IBT) is an established technique for the treatment of severe fetal anemia, increasing the survival of these fetuses. We aimed to describe the experience of a single center in pregnancies complicated with severe fetal anemia, that underwent IBT. Study design, Population, Methods: A retrospective cohort study was conducted from January 1996 to June 2014. Data were collected from 98 IBT performed in 44 pregnancies. Data included: anemia etiology, gestacional age at IBT, hemoglobin and hematocrit levels, presence of hydrops, number of IBTs, gestacional age at birth, sex and weight. Neonatal data included: number of exchange transfusions, respiratory distress syndrome, sepsis and other complications. Results: The main cause of fetal anemia was anti-D alloimmunization in 79.5% of the cases and the mean gestational age (GA) of the first IBT was 26 weeks. The minimum pre-transfusion hemoglobin was 1.5 g/dL, with an average of 6.4g/dL. The post transfusion hematocrit increased to the desired values in 90% of cases. Nine fetuses (20.5%) had hydrops at diagnosis. We had 4 cases of fetal death, and 40 pregnancies resulted in live births, with mean gestational age of 34.3 weeks, average weight of 2446g and mean hemoglobin of 11g/dL. A cesarean was performed in most cases. The overall survival was 86.4%, since in addition to the four fetal deaths there were two cases of early neonatal death. Fetal hydrops and early GA seemed to be associated with a poorer prognosis. Conclusions: IBT is a safe and effective procedure for the treatment of severe fetal anemia. Vigilance should be done in hospitals with experience to allow timely and proper treatment of this condition.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationActa Obstet Ginecol Port 2016;10(2):102-109pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4155
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.publisherFederação das Sociedades Portuguesas de Obstetrícia e Ginecologiapt_PT
dc.subjectIntrauterine blood transfusionpt_PT
dc.subjectCordocentesespt_PT
dc.subjectAnemiapt_PT
dc.subjectMAC OBSpt_PT
dc.titleIntrauterine Blood Transfusion for Fetal Anemia Treatment – The Experience of 14 Years of a Prenatal Diagnosis Center in Portugalpt_PT
dc.title.alternativeTransfusão Intra-Uterina para o Tratamento de Anemia Fetal Grave – Experiência de 14 anos de um Centro de Diagnóstico Pré-Natal em Portugalpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage109pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage102pt_PT
oaire.citation.volume10pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Acta Obstet GInecol Port 2016_102.pdf
Size:
130.62 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections